 REDWOOD CITY, Calif., Jan. 04, 2021 GLOBE NEWSWIRE -- Soleno Therapeutics, Inc. Soleno NASDAQ: SLNO, a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that management will present a corporate overview at the H.C. Wainwright Virtual BioConnect 2021 Conference, being held January 11-14, 2021. 